Fact CheckerSign in

NCT03962166Active, not recruiting

Characterizing Patients With POAF in Relation to Cardiac Surgery by wavECG and TTE

Characterizing Patients With Post-operative Atrial Fibrillation in Relation to Cardiac Surgery by Signal Processed Surface Electrocardiogram (wavECG) and Transthoracic Echocardiography A LAACS-2 Sub-study

Source: ClinicalTrials.gov · Last updated 16 Jan 2026

Brief summary (registry, in English)

Post-operative atrial fibrillation (POAF) is frequently observed after open-heart surgery. Despite numerous attempts to predict POAF, it remains a challenge to correctly identify the patients at risk. New technologies are available but not yet in cooperated in clinical guidelines and prediction models. We aim at identifying patients at risk of AF occurrence/recurrence after open-heart surgery by use of signal processed surface ECG (wavECG). The study is an explorative, prospective cohort study of 100 patients undergoing first-time elective open-heart surgery in the Left Atrial Appendage Closure by Surgery-2 (LAACS-2) trial (NCT03724318). Patients are examined by electrocardiogram (ECG), wavECG, transthoracic echocardiography and continuous heart rhythm monitoring. Primary endpoint is occurrence/recurrence of AF. Left ventricular diastolic dysfunction as evaluated by wavECG will be used to predict incidence of primary endpoint.

Status (registry)
Active, not recruiting
Study type
Observational
Enrollment
353 (actual)
First submitted
1 May 2019
Start date
7 Oct 2019
Primary completion date
30 Dec 2023
Lead sponsor
Helena DOMINGUEZ
NCT number
NCT03962166

What you commit to

  • Study type: Observational
  • Participants enrolled: 353
  • From 7 Oct 2019 to the primary completion date, 30 Dec 2023
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Planned ablation for atrial fibrillation during surgery

Other illness

  • Ongoing inflammation or infection (including endocarditis)
  • Connective tissue disease
  • Ongoing cancer (not control)

Other

  • Planned closure of the left atrial appendage
  • Pregnancy
  • Follow-up not possible

Who the study is looking for

  • Age \>18 years
  • First time open-heart surgery
  • Coronary artery bypass grafting and/or valve surgery
  • Signed informed consent

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Cardiology department Y, Bispebjerg-Frederiksberg Hospital
Coordinator of this site? Confirm its status
FrederiksbergDenmarkUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.